Pearce Samantha's Form 4 filing
Jazz Pharmaceuticals plc (JAZZ) · filed Jun 1, 2026
- Accession no.
- 0001805688-26-000008
- Filed
- Jun 1, 2026
- Trade date
- May 28, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.63M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pearce SamanthaCIK 0001805688 | Officer (EVP, Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 28, 2026 | Ordinary Shares | MOption exerciseAcquired | +6,907 | $109.45 | +$755,971.15 | 57,179 | Direct | |
| May 28, 2026 | Ordinary Shares | SSaleDisposed | −6,907 | $235.41 | −$1,625,976.87 | 50,272 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 28, 2026 | Ordinary Shares | MOption exerciseDisposed | −6,907 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.